Prognostic significance of tumor microenvironment assessed by machine learning algorithm in surgically resected non‐small cell lung cancer

Author:

Terada Yukihiro12ORCID,Isaka Mitsuhiro1,Ono Akira3,Kawata Takuya4,Serizawa Masakuni5,Mori Keita6,Muramatsu Koji4,Tone Kiyoshi4,Kenmotsu Hirotsugu3,Ohshima Keiichi7,Urakami Kenichi8,Nagashima Takeshi89,Kusuhara Masatoshi10,Akiyama Yasuto11,Sugino Takashi4,Takahashi Toshiaki3,Ohde Yasuhisa1

Affiliation:

1. Division of Thoracic Surgery Shizuoka Cancer Center Shizuoka Japan

2. Division of Thoracic Surgery Shinshu University School of Medicine Nagano Japan

3. Division of Thoracic Oncology Shizuoka Cancer Center Shizuoka Japan

4. Division of Pathology Shizuoka Cancer Center Shizuoka Japan

5. Drug Discovery and Development Division Research Institute, Shizuoka Cancer Center Shizuoka Japan

6. Clinical Research Center Shizuoka Cancer Center Shizuoka Japan

7. Medical Genetics Division Research Institute, Shizuoka Cancer Center Shizuoka Japan

8. Cancer Diagnostics Research Division Research Institute, Shizuoka Cancer Center Shizuoka Japan

9. SRL Inc Tokyo Japan

10. Region Resources Division Research Institute, Shizuoka Cancer Center Shizuoka Japan

11. Immunotherapy Division Research Institute, Shizuoka Cancer Center Shizuoka Japan

Abstract

AbstractBackgroundA methodology to assess the immune microenvironment (IME) of non‐small cell lung cancer (NSCLC) has not been established, and the prognostic impact of IME factors is not yet clear.AimsThis study aimed to assess the IME factors and evaluate their prognostic values.Methods and ResultsWe assessed CD8+ tumor‐infiltrating lymphocyte (TIL) density, forkhead box protein P3+ (Foxp3+) TIL density, and programmed death receptor ligand‐1 (PD‐L1) tumor proportion score (TPS) using a machine‐learning algorithm in whole‐slide imaging (WSI). We dichotomized patients according to TIL density or TPS and compared their clinical outcomes. Between September 2014 and September 2015, 165 patients with NSCLC were enrolled in the study. We assessed IME factors in the epithelium, stroma, and their combination. An improvement in disease‐free survival (DFS) was observed in the high CD8+TIL density group in the epithelium, stroma, and the combination of both. Moreover, the group with high PD‐L1 TPS in the epithelium showed better DFS than that with low PD‐L1 TPS. In the multivariate analysis, the CD8+TIL density in the combination of epithelium and stroma and PD‐L1 TPS in the epithelium were independent prognostic factors (hazard ratio [HR] = 0.43; 95% confidence interval [CI] = 0.26–0.72; p = .001, HR = 0.49; 95% CI = 0.30–0.81; p = .005, respectively).ConclusionOur approach demonstrated that the IME factors are related to survival in patients with NSCLC. The quantitative assessment of IME factors enables to discriminate patients with high risk of recurrence, who can be the candidates for adjuvant therapy. Assessing the CD8+TIL density in the combination of epithelium and stroma might be more useful than their individual assessment because it is a simple and time‐saving analysis of TILs in WSI.

Publisher

Wiley

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3